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Background: The role of body composition (lean mass and fat mass) on urine chemistries and bone quality is still
debated. Our aim was therefore to determine the effect of lean mass and fat mass on urine composition and bone
mineral density (BMD) in a cohort of healthy females.
Materials and methods: 78 female volunteers (mean age 46 ± 6 years) were enrolled at the Stone Clinic of Parma
University Hospital and subdued to 24-hour urine collection for lithogenic risk profile, DEXA, and 3-day dietary diary.
We defined two mathematical indexes derived from body composition measurement (index of lean mass-ILM, and
index of fat mass-IFM) and the cohort was split using the median value of each index, obtaining groups differing
only for lean or fat mass. We then analyzed differences in urine composition, dietary intakes and BMD.
Results: The women with high values of ILM had significantly higher excretion of creatinine (991 ± 194 vs 1138 ±
191 mg/day, p = 0.001), potassium (47 ± 13 vs 60 ± 18 mEq/day, p < 0.001), phosphorus (520 ± 174 vs 665 ± 186 mg/day,
p < 0.001), magnesium (66 ± 20 vs 85 ± 26 mg/day, p < 0.001), citrate (620 ± 178 vs 807 ± 323 mg/day, p = 0.002) and
oxalate (21 ± 7 vs 27 ± 11 mg/day, p = 0.015) and a significantly better BMD values in limbs than other women with low
values of ILM. The women with high values of IFM had similar urine composition to other women with low values of
IFM, but significantly better BMD in axial sites. No differences in dietary habits were found in both analyses.
Conclusions: Lean mass seems to significantly influence urine composition both in terms of lithogenesis promoters and
inhibitors, while fat mass does not. Lean mass influences bone quality only in limb skeleton, while fat mass influences
bone quality only in axial sites.
Keywords: Body composition, Lean mass, Fat mass, Bone mineral density, Urinary lithogenic risk factorsIntroduction
The role of body weight, body mass index and body
composition in the evaluation of lithogenic risk is still
controversial. Even if many studies show an increase in
the risk of developing nephrolithiasis with higher levels
of BMI, the exact contribution of lean mass and fat mass
in determining this risk is still unclear.
There are some large epidemiologic studies recording
a rise in the risk of kidney stones as body weight, BMI* Correspondence: antonio.nouvenne@alice.it
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reproduction in any medium, provided the orand abdominal circumference increase [1,2]. The rise in
the risk is however associated to a change in the type of
nephrolithiasis, with the prevalence of calcium stones
decreasing and the prevalence of uric acid stones in-
creasing [3-5]. A rise in lean body mass has been linked
to an increase in the incidence of nephrolithiasis only in
male [6]. Moreover, a loss of weight is not associated to
a decline in the risk [2].
On the other hand, if we consider urinary factors of
lithogenic risk, an inverse correlation between pH and
BMI and between pH and fat mass has been reported
[7]. Moreover, the excretion of oxalate has been linked
to body weight, body surface area and to lean mass [8].tral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and calcium rises when BMI increases [9-11]; however,
the calcium excretion loses significance after correction
for sodium and phosphate [9].
Some recent studies have also shown a positive rela-
tion between urinary lithogenic risk factors, overweight
and obesity [12-14]. Nevertheless, relative supersatura-
tions are not altered since even inhibitor excretion and
water intake increase with the body weight and/or BMI
percentiles growth. A common limit of many of these
studies is the lack of a precise evaluation of dietary
habits, particularly in protein intake [15,16].
Even the relation between body composition and bone
mineral density is debated. It has been demonstrated that
an increase in body weight improves bone mineral density,
but the specific role of lean mass and fat mass remains un-
certain such as different effects in men and women [17].
There is a positive relation, proven in many studies, be-
tween fat mass and vertebral bone mineral density, while
lean mass seems to be related to a higher bone mineral
density only in some areas and is highly influenced by age
and physical exercise [18-20]. On the other hand a link be-
tween urine chemistries, body composition and bone min-
eral density has been described [21,22].
In this paper, basing on a cohort of healthy women, we
identified two new mathematical indexes pointing out the
role of lean body mass and fat body mass separately, trying
to eliminate possible confounding factors (e.g. height)
present in already validated indices such as the Fat-Free
Mass Index and Fat Mass Index [23]. Therefore we veri-
fied: 1) whether the urinary excretion of lithogenic risk
factors is influenced by the whole body weight or by its
composition in lean mass and fat mass; 2) how the bone
mineral density is related to body composition; 3) which
are the body areas where lean mass or fat mass most influ-
ence bone mineral density.
Materials and methods
Participants
We studied 78 healthy female volunteers at the Stone Clinic
of the Clinical and Experimental Medicine Department,
Parma University Hospital, Italy. Approvation by Ethical
Committee of Parma Province was obtained as well as
written informed consent from the patient for the pub-
lication of this report and any accompanying images.
The study was carried out in compliance with the
Helsinki Declaration.
All women carried out: 1) 24-hour urine collection for
the laboratory determination of urinary lithogenic risk fac-
tors; 2) bone mineral density and body composition meas-
urement through Dual-Energy X-Ray Absorptiometry
with a fan-beam Hologic QDR 4500A densitometer
(Hologic, Bedford, Mass., USA); 3) 3-day dietary diary
in non-consecutive days with one corresponding to theday of the urinary collection, subsequently analyzed by
a dietitian and interpreted with a specific software
(Dietosystem, DS Medica, Milano, Italy).
Densitometry
Body Composition was measured by DEXA with a fan
beam densitometer (Hologic QDR 4500 A) and dedi-
cated software (rel. 8.2). In the DEXA measurement, a
trained physician performed the measurements on the
women. DEXA measurements were performed following
standard procedures, according to the manufacturer’s
guidelines, while the participant was lying in a supine
position. The trunk was considered as the region
delimited by a horizontal line passing under the chin,
two vertical lines passing through the medial margin of
the head of the homerus, excluding all of the upper
limbs, and two oblique lines at the groin cutting midway
through the neck of the femur and crossing below the
pubis. Intra-site repeatability was a mean of 2–3 & for
FM. The coefficients of variation for the method were
assessed by repeated measurements.
Definition of mathematical indexes for body lean mass
and body fat mass
Index of lean mass (ILM)
We defined an index in order to obtain two groups of
women not different for body weight and BMI but only
for lean mass. Body weight (BW), lean mass (LM) and
fat mass (FM) are not independent variables because we
can assume that total body weight is the sum of lean
mass and fat mass.
ILM has been conceived for not being influenced by
body weight, i.e.:
Since
BW ¼ LMþ FM
Then
ILM ¼ BW  LM–FMð Þ
That we can also write as
ILM ¼ LMþ FMð Þ  LM–FMð Þ
And therefore
ILM ¼ LM2–FM2
Since every woman studied has a lean body mass
higher than the fat body mass, elevating their values to
the power of two we obtain the higher difference the
heavier the lean mass is.
Therefore we calculated the value of ILM for every
woman involved in the study, we found its median and
we split our population in two groups (group A with
ILM values lower than the median and group B with
Table 1 Discriminant function analysis for body
composition of healthy women split into two groups
based on the Index of Lean Mass (ILM)
Parameter Standardized canonical
discriminant function coefficient (*)
Index of Lean Mass (ILM) 0.81
Total lean mass, Kg 0.44
Height, cm 0.31
BMD upper limb, g/cm2 0.25
(*) Parameters with coefficient > 0.25. Lambda of Wilks (p < 0.001).
BMD: Bone Mineral Density.
Table 2 Discriminant function analysis for urinary
lithogenic risk factors on a 24-hour urine collection in
healthy women split into two groups based on the Index
of Lean Mass (ILM)
Parameter Standardized canonical
discriminant function coefficient (*)
Potassium, mEq/24 h 0.52
Magnesium, mg/24 h 0.51
Phosphorus, mg/24 h 0.50
Creatinine, mg/24 h 0.48
Citrate, mg/24 h 0.44
Oxalate, mg/24 h 0.35
Sodium, mEq/24 h 0.26
(*) Parameters with coefficient > 0.25. Lambda of Wilks (p = 0.003).
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were characterized by a strong difference in lean body
mass (p < 0.0001), but were not significantly different for
fat mass, body weight and BMI.
Index of fat mass (IFM)
We defined an index in order to obtain two groups not
differing for lean mass:
IFM ¼ BW= LM–FMð Þ and therefore IFM
¼ LMþ FMð Þ= LM–FMð Þ
Since an increase in body weight is generally associ-
ated to an increase both in lean mass and in fat mass,
but the extent of the increase is higher for fat mass, the
higher is body weight, the higher is the numerator and
the lower is the difference between lean mass and fat
mass, and, subsequently, the higher is the value of IFM.
Thus, we calculated the value of IFM for every subject
studied, we found its median and subsequently split our
population into two groups (group C with IFM values
lower than the median and group D with IFM values
higher than the median). These two groups are charac-
terized by a strong difference in fat mass, body weight
and BMI (p < 0.0001), while there are no significant dif-
ferences for the lean mass composition.
Statistical analysis
Data distribution was assessed using Shapiro-Wilk’s test.
Data were reported as media and standard deviation
(SD). Data with deviations from normality were shown
as median and range. Differences between the two
groups in all tables were calculated using independent
Student’s t-test or Mann-Whitney’s U-test. A p value
lower than 0.05 was considered significant for t-test or
U-test. Holm’s test [24] was applied to adjust p values
for multiple comparisons. Holm’s statistical procedures
rejected an hypothesis only if its p-value was less than
their corresponding critical values. Holm’s test was
supported also by a discriminant analysis reported in
Tables 1, 2 and 3 Pearson’s correlation coefficient (r) was
reported for all parameters quantified. The data were
statistically analysed using SPSS 20.0 (SPSS inc. Chicago,
IL, USA).
Results
The average age of the 78 women studied was 46 ±
6 years (range 31–59). 24% of them (19 women) had
been menopausal since at least one year.
ILM and IFM validation
Indexes validation was carrying out as follows. Weight,
total lean mass and total fat mass are parameters
strongly correlated to each other (weight vs total leanmass, r = 0.839 and p < 0.0001; weight vs total fat mass,
r = 0.909 and p < 0.0001; total fat mass vs total lean mass,
r = 0.538 and p < 0.0001, where r is a Pearson’s correl-
ation coefficient). Multiple regression can be performed
using least-squares method: total lean mass is dependent
variable and weight is predictor, ILM (Index of Lean
Mass) is reported in the model as covariate variable. This
multiple regression is highly significant with p < 0.0001,
R2 = 0.989 and R = 0.995. A simple linear regression with
only weight as independent variable resulting R2 = 0.70
and R = 0.84. So ILM is very important in the explanation
of the model. Total lean mass adjusted for weight corre-
lates significantly with different parameters of urinary ex-
cretion and density bones. These Pearson’s correlations
provide results equal to values obtained from the correla-
tions of ILM with same parameters. ILM is independent
from the weight and also from BMI. For example two sub-
jects may have the same weight’s and height’s values (same
BMI), but lean total mass completely different. ILM is a
parameter more specific for total lean mass. Now it is
clear that subjects with high lean total mass not have
necessary low total fat mass. The second index IFM corre-
lates highly significant with total fat mass, r = 0.689 and
p < 0.0001 and it is not correlated with total lean mass.
These correlations are confirmed by Discriminant Function
Table 3 Discriminant function analysis for body
composition in healthy women split into two groups
based on the Index of Fat Mass (IFM)
Parameter Standardized canonical
discriminant function coefficient (*)
Total fat mass, Kg 0.67
BMI, Kg/m2 0.51
Weight, Kg 0.41
Total lower limb mass, Kg 0.41
Total trunk mass, Kg 0.37
Index of Fat Mass (IFM) 0.26
(*) Parameters with coefficient > 0.25. Lambda of Wilks (p < 0.001).
BMI: Body Mass Index.
Table 4 Body composition of healthy women split into two g
Group A
Low lean mass H
ILM < 1296
N. 39
ILM 1035 ± 205
Age, years 46 ± 6
Menopausal, n., % (°) 11 (28)
Years from menopause 1.4 ± 3
Weight, Kg 65 ± 10
Height, cm 159 ± 6
BMI, Kg/m2 26 ± 4
Total trunk mass, Kg 31 ± 5
Total lower limb mass, Kg 22 ± 4
Total lean mass, Kg 40 ± 4
Total fat mass, Kg 23 ± 6
BMD upper limbs, g/cm2 0.72 ± 0.04
BMD ribs, g/cm2 0.64 ± 0.08
BMD lower limbs, g/cm2 1.10 ± 0.07
BMD pelvis, g/cm2 1.20 ± 0.15
BMD lumbar vertebrae, g/cm2 1 ± 0.13
BMD femur, g/cm2 0.91 ± 0.12
T-score lumbar vertebrae (+) −0.17 (−2.50 – 2.31) −0
Z-score lumbar vertebrae (+) 0.41 (−1.92 – 2.73) 0.3
T-score femur (+) −0.16 (−1.92 – 2.07) −0
Z-score femur (+) 0.27 (−1.52 – 2.43) 0.3
Data were reported as mean ± standard deviation (SD), unless otherwise specified.
°Data were reported as number of subjects (frequency).
+Data were reported as median and range.
*p value was calculated with nondependent Student’s t test, unless otherwise speci
**χ2 test was applied to evaluate p value.
***Mann-Whithey’s u-test was applied to evaluate p value.
###Significant differences with p adjusted by Holm’s test.
BMD: Bone Mineral Density.
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coefficients reported in Tables 1, 2 and 3.
Table 4 shows the values of body composition and
Table 5 shows the urinary lithogenic risk factors after
partition of the women according to the median (1296)
of the Index of Lean Mass. Groups A and B did not dif-
fer in body weight and BMI, but women in group B
showed height and lean mass significantly higher (159 ± 6
vs 163 ± 5 cm and 40 ± 4 vs 45 ± 5 kg, p < 0.0001). More-
over, the group with high ILM showed a bone mineral
density significantly higher in both upper and lower limbs
and in ribs (Table 4).
The subjects of group B (with high lean mass) also
showed urinary excretion of creatinine, potassium, phos-
phorus, magnesium, citrate and oxalate significantly
higher than the ones of group A (Table 5).roups based on the Index of Lean Mass (ILM)
Group B p (*) p critical values
(0.0029 < p < 0.0025)igh lean mass
ILM > 1296
N. 39
1625 ± 313 <0.0001 ###
46 ± 6 0.956
8 (21) 0.590**
0.9 ± 2 0.416
68 ± 11 0.268
163 ± 5 <0.0001 ###
25 ± 4 0.612
32 ± 6 0.289
23 ± 4 0.460
45 ± 5 <0.0001 ###
21 ± 7 0.07
0.76 ± 0.08 0.003 ###
0.68 ± 0.07 0.035
1.15 ± 0.1 0.026
1.24 ± 0.18 0.307
1.04 ± 0.15 0.217
0.95 ± 0.11 0.232
.45 (−2.54 – 2.87) 0.442***
4 (−1.49 – 3.21) 0.407***
.09 (−1,50 – 1.52) 0.165***
7 (−1.27 – 1.93) 0.225***
fied.
Table 5 Urinary lithogenic risk factors on a 24-hour urine collection in healthy women split into two groups based on
the Index of Lean Mass (ILM)
Group A Group B P (*) p critical values
(0.0038 < p < 0.003)Low lean mass High lean mass
ILM < 1296 ILM > 1296
N. 39 N. 39
Volume, ml 1603 ± 698 1640 ± 835 0.832
Creatinine, mg/24 h 991 ± 194 1138 ± 191 0.001 ###
Urea, mg/24 h 22 ± 6 23 ± 6 0.486
Sodium, mEq/24 h 124 ± 49 143 ± 45 0.072
Potassium, mEq/24 h 47 ± 13 60 ± 18 <0.001 ###
Calcium, mg/24 h 156 ± 62 188 ± 91 0.076
Phosphorus, mg/24 h 520 ± 174 665 ± 186 <0.001 ###
Magnesium, mg/24 h 66 ± 20 85 ± 26 <0.001 ###
Chloride, mEq/24 h 131 ± 50 151 ± 49 0.074
Uric acid, mg/24 h 456 ± 136 508 ± 116 0.077
Citrate, mg/24 h 620 ± 178 807 ± 323 0.002 ###
Oxalate, mg/24 h 21 ± 7 27 ± 11 0.015
Sulfate, mmol/24 h 16 ± 4 18 ± 5 0.085
Ammonium, mmol/24 h 27 ± 11 30 ± 9 0.275
pH 24 h 5.95 ± 0.51 5.96 ± 0.45 0.961
Data were reported as mean ± standard deviation (SD).
*p value was calculated with independent Student’s t-test.
###Significant differences with p adjusted by Holm’s test.
Table 6 Dietary intake of healthy women split into two
groups based on the Index of Lean Mass (ILM)
Group A Group B p (*)
Low lean mass High lean mass
ILM < 1296 ILM > 1296
N. 39 N. 39
Water, ml 1470 ± 560 1470 ± 670 1.000
PRAL, mEq 12.75 ± 17.45 6.69 ± 18.85 0.145
Proteins, g/24 h 82 ± 22 89 ± 30 0.215
Carbohydrates, g/24 h 258 ± 89 272 ± 92 0.493
Lipids, mEq/24 h 82 ± 29 93 ± 29 0.101
Sodium, mEq/24 h 80 ± 44 95 ± 61 0.212
Potassium, mEq/24 h 66 ± 18 73 ± 23 0.150
Calcium, mg/24 h 757 ± 416 842 ± 347 0-330
Phosphorus, mg/24 h 1150 ± 418 1105 ± 350 0.610
Magnesium, mg/24 h 261 ± 97 295 ± 126 0.181
Data were reported as mean ± standard deviation (SD).
*p value was calculated with independent Student’s t-test.
PRAL: Potential Renal Acid Load. The Dietosystem software (DS Medica)
calculates PRAL applying the original model described by Remer and
Manz (ref).
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ferences in the intake of water. Potential Renal Acid Load
(PRAL calculated) [25], proteins, carbohydrates, lipids, so-
dium, potassium, calcium, phosphorus, and magnesium did
not show differences between the two ILM groups (Table 6).
The percentage of subjects that regularly performed
physical exercise (according to WHO guidelines [26])
was not significantly different as well (Group A 31% vs
Group B 49%, p = 0.105).
Table 7 shows the values of body composition and
Table 8 the urinary lithogenic risk factors after subdiv-
ision of the women according to the median (3.28) of
the Index of Fat Mass. The two groups did not differ in
height, but the group with a higher IFM showed signifi-
cantly greater values of BMI, total trunk mass, total leg
mass and total body fat mass. The bone mineral density
of the pelvis, lumbar vertebrae and femur, and the re-
spective T and Z score, were significantly better in
Group D, the one with high IFM (Table 7).
The urinary lithogenic risk factors (Table 8) showed no
differences between Group C (subjects with low IFM) and
Group D (subjects with high IFM); besides, even dietary
intakes did not reveal significant differences (Table 9). The
percentage of subjects regularly performing physical activ-
ity appeared instead significantly higher in women with a
low Index of Fat Mass (Group C 54% vs Group D 26%,
p = 0.01).
Table 7 Body composition in healthy women split into two groups based on the Index of Fat Mass (IFM)
Group C Group D p (*) p critical value
(0.0036 < p < 0.0025)Low fat mass High fat mass
IFM < 3.28 IFM > 3.28
N. 39 N. 39
IFM 2.50 ± 0.42 5.14 ± 4.03 <0.0001 ###
Age, years 45 ± 6 47 ± 6 0.23
Menopause, n., % (°) 8 (21) 11 (28) 0.429**
Years from menopause 0.8 ± 3 1.5 ± 3 0.336
Weight, Kg 60 ± 7 73 ± 10 <0.0001 ###
Height, cm 161 ± 6 161 ± 6 0.467
BMI, Kg/m2 23 ± 2 28 ± 3 <0.0001 ###
Total trunk mass, Kg 28 ± 4 35 ± 6 <0.0001 ###
Total lower limb mass, Kg 21 ± 3 25 ± 3 <0.0001 ###
Total lean mass, Kg 41 ± 5 43 ± 5 0.064
Total fat mass, Kg 17 ± 3 27 ± 5 <0.0001 ###
BMD upper limbs, g/cm2 0.74 ± 0.08 0.73 ± 0.06 0.347
BMD ribs, g/cm2 0.66 ± 0.08 0.66 ± 0.07 0.886
BMD lower limbs, g/cm2 1.13 ± 0.09 1.13 ± 0.09 0.896
BMD pelvis, g/cm2 1.18 ± 0.15 1.27 ± 0.17 0.013
BMD lumbar vertebrae, g/cm2 0.98 ± 0.13 1.06 ± 0.14 0.018
BMD femur, g/cm2 0.90 ± 0.10 0.96 ± 0.12 0.025
T-score lumbar vertebrae (+) −0.55 (−2.54 – 2.87) 0.25 (−2.50 – 2.68) 0.013***
Z-score lumbar vertebrae (+) −0.13 (−1.92 – 3.19) 0.63 (−1.46 – 3.21) 0.004***
T-score femur (+) −0.52 (−1.55 – 1.25) 0.24 (−1.92 – 2–07) 0.034***
Z-score femur (+) −0.18 (−1.27 – 1.93) 0.61 (−1.52 – 2.43) 0.014***
Data were reported as mean ± standard deviation (SD), unless otherwise specified.
°Data were reported as number of patients (frequency).
+ Data were reported as median and range.
*p value was calculated with independent Student’s t-test, unless otherwise specified.
**χ2 test was applied to evaluate p value.
***Mann-Whitney’s u-test was applied to evaluate p-value.
###Significant differences with p adjusted by Holm’s test.
BMD: Bone Mineral Density.
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urine chemistries regarding ILM and IFM are reported in
Tables 1 and 2 for ILM and Table 3 for IFM.
Discussion
Our data demonstrate that the urine composition in our co-
hort of female healthy volunteers is significantly influenced
by the body composition in lean mass. A high lean mass
promotes a high excretion both of some lithogenesis pro-
moters, such as phosphate and oxalate, and of some
lithogenesis inhibitors, such as magnesium, potassium and
citrate. A positive trend also seems to occur with other urin-
ary analytes such as sodium, chloride, uric acid and sulphate,
although at the limit of statistical significance, perhaps be-
cause of the relatively low number of subjects studied.
It seems plausible to argue that these findings were
not due to differences in dietary intake, as demonstratedby a nutritional analysis performed through a 3-day
dietary diary. We can therefore assume that lean mass
plays an active role in determining urine composition,
while fat mass seems to act as a metabolically inactive
bystander.
This hypothesis partially conflicts with the current
paradigm that considers nephrolithiasis as a systemic
disorder strongly linked to metabolic syndrome. There
are data showing that a high insulin resistance, possible
expression of a high fat mass, leads to lower urinary pH,
to a high acid load and ammonium excretion [27]. This
would expose subjects with a high fat mass to a higher
risk of uric acid stones, although there are also data
linking various features of the metabolic syndrome to
calcium nephrolithiasis too [28]. These findings may ex-
plain the strong epidemiologic correlation between obes-
ity and kidney stones [3-5].
Table 8 Urinary lithogenic risk factors on a 24-hour urine
collection in healthy women, split into two groups based
on the Index of Fat Mass (IFM)
Group C Group D p (*)
Low fat mass High fat mass
IFM < 3.28 IFM > 3.28
N. 39 N. 39
Volume, ml 1692 ± 793 1551 ± 740 0.418
Creatinine, mg/24 h 1034 ± 201 1095 ± 207 0.188
Urea, mg/24 h 22 ± 6 22 ± 6 0.807
Sodium, mEq/24 h 130 ± 45 137 ± 51 0.501
Potassium, mEq/24 h 55 ± 18 53 ± 17 0.677
Calcium, mg/24 h 178 ± 90 167 ± 67 0.537
Phosphorus, mg/24 h 574 ± 196 611 ± 192 0.402
Magnesium, mg/24 h 80 ± 28 71 ± 21 0.138
Chloride, mEq/24 h 138 ± 48 144 ± 53 0.622
Uric acid, mg/24 h 469 ± 120 495 ± 136 0.363
Citrate, mg/24 h 736 ± 292 691 ± 261 0.478
Oxalate, mg/24 h 23 ± 7 26 ± 12 0.162
Sulfate, mmol/24 h 17 ± 4 17 ± 5 0.526
Ammonium, mmol/24 h 28 ± 9 29 ± 12 0.881
pH 24 h 6.00 ± 0.43 5.92 ± 0.53 0.451
Data were reported as mean ± standard deviation (SD).
*p value was calculated with independent Student’s t-test.
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ectly suggesting that fat mass does not affect lithogenic
risk until BMI rises to the range of morbid obesity. For
example, Taylor et al. found that lithogenic risk does not
rise for a body weight up to 67.7 kg and a BMI up to
27.7 kg/m2. Moreover, some recent data show thatTable 9 Dietary intake of healthy women split into two
groups based on of the Index of Fat Mass (IFM)
Group C Group D p (*)
Low fat mass High fat mass
IFM < 3.28 IFM > 3.28
N. 39 N. 39
Water, ml 1530 ± 650 1410 ± 580 0.371
PRAL, mEq 11.30 ± 16.60 6.10 ± 20.02 0.217
Proteins, g/24 h 90 ± 29 81 ± 20 0.131
Carbohydrates, g/24 h 278 ± 92 252 ± 87 0.204
Lipids, mEq/24 h 93 ± 32 82 ± 25 0.112
Sodium, mEq/24 h 92 ± 59 82 ± 25 0.112
Potassium, mEq/24 h 71 ± 23 68 ± 19 0.521
Calcium, mg/24 h 880 ± 403 719 ± 349 0.062
Phosphorus, mg/24 h 1199 ± 440 1056 ± 308 0.100
Magnesium, mg/24 h 288 ± 114 268 ± 112 0.426
Data were reported as mean ± standard deviation.
*p value was calculated with independent Student’s t-test.obesity does seem to determine a higher risk of
nephrolithiasis in a children cohort, but surprisingly
does not influence urine chemistries at all [22]. Finally,
another recent report shows that in obese stone formers
body composition does not influence stone chemistry
until very high levels of BMI (> 40 kg/m2) are reached
[29], thus indirectly supporting our finding that urine
chemistry is poorly influenced by fat mass. In fact, it is
remarkable to point out that in our research there was
an average difference in body weight of about 13 kg be-
tween group C (low fat mass) and group D (high fat
mass) (Table 7).
The relationship between lean mass and urine com-
position has been indeed poorly investigated in litera-
ture. However, our findings partially match with those
by Lemann jr et al., who demonstrated that oxalate and
calcium excretion in males is directly related to creatin-
ine excretion, an index of lean mass composition, in a
cohort of healthy subjects [8]. Thus, the increase of
lean mass might cause a rise in the risk for calcium
nephrolithiasis.
We may speculate that a high lean mass leads to higher
protein catabolism, thus influencing the differences in
urine composition we found in our research. We must
also point out that subjects in group B, the ones with a
high lean mass, had also a higher prevalence of physical
exercise, although not statistically significant. It is plaus-
ible that physical exercise may influence a more active
muscular metabolism, thus causing a higher excretion of
metabolites such as oxalate, phosphate and citrate.
The analysis of bone mineral density in our subjects
confirmed the assumption, already well established in lit-
erature [18], that the higher is the body mass, the better
is the quality of the bone, particularly in the spine
(Table 7). The women with high IFM had a significantly
higher bone mineral density in lumbar vertebrae, pelvis
and femur. This group also shows a poor percentage of
subjects regularly performing physical activity (26% vs
54%). This tallies with published data showing that in
premenopausal sedentary women bone mineral density
correlates with fat mass [30]. However, we have to con-
sider that in our model total body weigh increase when
fat mass rise suggesting a non-linear dose–response rela-
tionship of fat mass on BMD as previous suggested [17].
On the other hand, the group with high lean mass shows
better mineral density in upper and lower limbs and ribs.
This group also includes subjects taller than the ones
with low lean mass. It has already been demonstrated
that height correlates with lean mass and mineral dens-
ity of extra-axial bones [30,31]. We can also suppose
that a better bone mineral density in limbs and ribs is, at
least partially, due to physical exercise with a subsequent
increase in muscle mass and mechanic anabolic stimulus
on the bone [32,33].
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http://www.translational-medicine.com/content/11/1/248We are aware of some limits that are implied in our
study. First, the number of subjects studied is rather low.
Secondly, the groups were split on the basis of mathemat-
ical indexes built to highlight lean mass and fat mass and
not on the basis of direct measures. Moreover, we did not
carry out an analysis distinguishing pre-menopausal and
post-menopausal women. Finally, the analysis of a three-
day dietary diary may not exhaustively capture the real
dietary habits of a subject; nevertheless the diaries were
interpreted by a dietitian during a meeting and the results
do not change even after correction for body weight.
Conclusions
This paper suggests that in healthy women with a simi-
lar dietary intake, fat mass does not seem to influence
the urinary excretion of lithogenic risk factors, which on
the other hand seems to be much more dependent on
the level of lean mass. Moreover, bone mineral density
seems to be influenced by fat mass, while lean mass
might play a positive role particularly on the extra-axial
skeleton, as a possible result of the muscular activity.
However, the field of interactions between body compos-
ition and mineral metabolism is far from being fully
understood. Further research on larger cohorts both of
healthy subjects and kidney stone formers or people
with osteoporosis will clarify the specific role of lean
mass and fat mass.
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